These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22513953)

  • 1. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2012 Apr; (4):CD007791. PubMed ID: 22513953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Brassington R; Pandolfo M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007791. PubMed ID: 27572719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants and other pharmacological treatments for Friedreich ataxia.
    Kearney M; Orrell RW; Fahey M; Pandolfo M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007791. PubMed ID: 19821439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for speech disorder in Friedreich ataxia and other hereditary ataxia syndromes.
    Vogel AP; Folker J; Poole ML
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008953. PubMed ID: 25348587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia.
    Lynch DR; Perlman SL; Meier T
    Arch Neurol; 2010 Aug; 67(8):941-7. PubMed ID: 20697044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
    Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for mitochondrial disorders.
    Pfeffer G; Majamaa K; Turnbull DM; Thorburn D; Chinnery PF
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD004426. PubMed ID: 22513923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence of interventions assessed in Friedreich ataxia: a systematic review.
    Jain P; Badgujar L; Spoorendonk J; Buesch K
    Ther Adv Rare Dis; 2022; 3():26330040221139872. PubMed ID: 37180421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological, cardiological, and oculomotor progression in 104 patients with Friedreich ataxia during long-term follow-up.
    Ribaï P; Pousset F; Tanguy ML; Rivaud-Pechoux S; Le Ber I; Gasparini F; Charles P; Béraud AS; Schmitt M; Koenig M; Mallet A; Brice A; Dürr A
    Arch Neurol; 2007 Apr; 64(4):558-64. PubMed ID: 17420319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up.
    Pineda M; Arpa J; Montero R; Aracil A; Domínguez F; Galván M; Mas A; Martorell L; Sierra C; Brandi N; García-Arumí E; Rissech M; Velasco D; Costa JA; Artuch R
    Eur J Paediatr Neurol; 2008 Nov; 12(6):470-5. PubMed ID: 18234531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA).
    Lagedrost SJ; Sutton MS; Cohen MS; Satou GM; Kaufman BD; Perlman SL; Rummey C; Meier T; Lynch DR
    Am Heart J; 2011 Mar; 161(3):639-645.e1. PubMed ID: 21392622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia.
    Velasco-Sánchez D; Aracil A; Montero R; Mas A; Jiménez L; O'Callaghan M; Tondo M; Capdevila A; Blanch J; Artuch R; Pineda M
    Cerebellum; 2011 Mar; 10(1):1-8. PubMed ID: 20865357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idebenone treatment in Friedreich patients: one-year-long randomized placebo-controlled trial.
    Rustin P; Bonnet D; Rötig A; Munnich A; Sidi D
    Neurology; 2004 Feb; 62(3):524-5; author reply 525; discussion 525. PubMed ID: 14872056
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone.
    Cook A; Boesch S; Heck S; Brunt E; Klockgether T; Schöls L; Schulz A; Giunti P
    Acta Neurol Scand; 2019 Jun; 139(6):533-539. PubMed ID: 30887496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idebenone in Friedreich's ataxia.
    Tonon C; Lodi R
    Expert Opin Pharmacother; 2008 Sep; 9(13):2327-37. PubMed ID: 18710357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose idebenone treatment in Friedreich's ataxia with and without cardiac hypertrophy.
    Rinaldi C; Tucci T; Maione S; Giunta A; De Michele G; Filla A
    J Neurol; 2009 Sep; 256(9):1434-7. PubMed ID: 19363628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants for male subfertility.
    Showell MG; Mackenzie-Proctor R; Brown J; Yazdani A; Stankiewicz MT; Hart RJ
    Cochrane Database Syst Rev; 2014; (12):CD007411. PubMed ID: 25504418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idebenone: an emerging therapy for Friedreich ataxia.
    Meier T; Buyse G
    J Neurol; 2009 Mar; 256 Suppl 1():25-30. PubMed ID: 19283347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Friedreich's ataxia: idebenone treatment in early stage patients.
    Artuch R; Aracil A; Mas A; Colomé C; Rissech M; Monrós E; Pineda M
    Neuropediatrics; 2002 Aug; 33(4):190-3. PubMed ID: 12368988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with high-dose idebenone in Friedreich ataxia.
    Schulz JB; Di Prospero NA; Fischbeck K
    J Neurol; 2009 Mar; 256 Suppl 1(0 1):42-5. PubMed ID: 19283350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.